DT
TXG icon

Diversified Trust’s 10x Genomics TXG Stock Holding History

Diversified Trust’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-66,741
Closed -$773K – 1064
2025
Q2 		$773K Buy
66,741
+9,505
+17% +$86.6K 0.02% 452
2025
Q1 		$500K Buy
57,236
+21,634
+61% +$273K 0.01% 577
2024
Q4 		$511K Buy
+35,602
New +$562K 0.01% 594

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Diversified Trust's TXG Position: Q3 2025 in Review

Diversified Trust sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 66,741 shares — an estimated $773K sold.

Diversified Trust first reported a position in TXG in Q4 2024 and held it in 3 quarters. The position peaked at $773K in Q2 2025. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • Diversified Trust reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • Diversified Trust sold 66,741 10x Genomics shares in Q3 2025, an estimated $773K.
  • Diversified Trust first reported a position in 10x Genomics in Q4 2024 and held it in 3 quarters.
  • Diversified Trust's 10x Genomics position peaked at $773K in Q2 2025.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Diversified Trust's 13F filing for Q3 2025, filed 20 Oct 2025.